Form 8-K TG THERAPEUTICS, INC. For: Mar 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
TG Therapeutics (TGTX) Misses Q4 EPS by 22c
March 11, 2015 5:08 PM EDTTG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), $0.22 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
... More